Latest News

Patients with oropharyngeal cancer report quality of voice, speech affected post-treatment

Oropharyngeal cancer patients treated with combined chemotherapy and radiation therapy reported a decrease in their voice and speech quality (VSQ) for up to one year after the completion of treatment, according to research. The study further shows that limiting the dose of radiation to the glottic larynx (GL) to less than 20 Gy resulted in a decrease in post-treatment VSQ problems, and that patient-reported VSQ indicated more adverse effects from treatment compared to independent physician assessment.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Multiple sclerosis: Review of current treatments for physicians

  • Researchers compare hip width and sexual behavior

  • Some astronauts at risk for cognitive impairment, animal studies suggest

  • Hearing quality restored with bionic ear technology used for gene therapy: Re-growing auditory nerves

  • Finding safe drugs to treat neurodegenerative diseases

  • Loss of memory in Alzheimer's mice models reversed through gene therapy

  • Novel compound halts cocaine addiction, relapse behaviors

  • Safer alternatives to nonsteroidal antinflamatory pain killers

  • Mystery behind general anesthetic action becoming more clear

  • Narrowing of neck artery without warning may signal memory, thinking decline

  •